Bard Peripheral Vascular, Inc.: FDA filings under this applicant name

FDA lists 39 510(k) clearances under 2 spellings of the applicant name “Bard Peripheral Vascular, Inc.” (first 2003, latest 2026), plus 7 PMA decisions, across 22 product codes in 5 review panels. Median 510(k) review time under this name: 41 days. Since 2017 the median was 84 days, against 108 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under BD (Becton, Dickinson and Company), based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
2012317
2013232
2014250
20150—
20162135
20172134
2018160
2019229
20200—
2021226
2022260
2023192
20241156
20255140
2026226

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Bard Peripheral Vascular, Inc. took a median 84 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 108 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
KNWInstrument, Biopsy88
LITCatheter, Angioplasty, Peripheral, Transluminal66
DQYCatheter, Percutaneous55
NEUMarker, Radiographic, Implantable33
DSYProsthesis, Vascular Graft, Of 6mm And Greater Diameter22
DTKFilter, Intravascular, Cardiovascular22
FGEStents, Drains And Dilators For The Biliary Ducts22
JCTProsthesis, Tracheal, Expandable22
PFVSystem, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment20
PNOCatheter, Percutaneous, Cutting/Scoring22

Plus 12 more product codes.

Review panels

Most recent Bard Peripheral Vascular, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K262571EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemKNW2026-08-1421
K260012UltraScore™ Focused Force PTA BalloonPNO2026-02-0430
K252681EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemKNW2025-12-12109
K250032Marquee™ Disposable Core Biopsy Instrument and Instrument KitKNW2025-07-10184
K250219Dorado™ PTA Balloon Dilatation CatheterDQY2025-06-17144
K243642UltraCor™ Twirl™ Breast Tissue MarkerNEU2025-03-24118
K242757Rotarex Atherectomy SystemMCW2025-01-30140
K241946PeritX™ 1L Drainage Kit (90-1010); PeritX™ 2L Drainage Kit (90-2010); PeritX™ Peritoneal Catheter Kit (50-9000C); PeritX™ Peritoneal Catheter and Starter Kit (50-9900C); PeritX™ Peritoneal Catheter Mini Kit (50-9050A); PleurX™ Low Profile Catheter Mini Kit (50-8050); Valve Cap (50-7235A); PeritX™ Valve Kit (50-7272); Catheter Access Kit (50-7280A); Lockable Drainage Line (50-7245A); Lockable Drainage Line Kit (50-7265A); PleurX™ Supplemental Insertion Kit (50-7262); Procedure Pack (50-PNG2024-12-06156
K232737PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port; PowerPort™ ClearVUE™ isp ECG Enabled Implantable Port; PowerPort™ isp M.R.I.™ ECG Enabled Implantable Port; PowerPort™ Slim ECG Enabled Implantable PortLJT2023-12-0892
K221440Liverty™ TIPS Access SetDYB2022-05-3114

29 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P250050PMALiverty™ TIPS Stent Graft2026-09-25
P180037PMAVenovo Venous Stent System2019-03-13
P160024PMALIFESTREAM BALLOON EXPANDABLE VASCULAR COVERED STENT2017-04-24
P130029PMAFLUENCY PLUS ENDOVASCULAR STENT GRAFT2014-06-17
P070014PMALIFESTENT FLEXSTAR & FLEXSTAR XL VASCULAR STENT SYSTEM2009-02-13

Recalls

237 product recalls in 69 recall events; 28 initiated in the last five years. Most recent: 2026-08-20.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Parent company SEC filings

BECTON DICKINSON & CO (BDX): EDGAR filings, CIK 10795. Caduvo groups Bard Peripheral Vascular, Inc. under BD (Becton, Dickinson and Company); the parent's SEC registrant is entered by hand for the group, not matched by name.

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Bard Peripheral Vascular, Inc.?

FDA lists 39 510(k) clearances under 2 spellings of the applicant name “Bard Peripheral Vascular, Inc.” (first 2003, latest 2026), plus 7 PMA decisions, across 22 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Bard Peripheral Vascular, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Bard Peripheral Vascular, Inc. is 41 days. Since 2017: 84 days, versus 108 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Bard Peripheral Vascular, Inc.?

The most frequent FDA product codes under this applicant name are KNW (Instrument, Biopsy, 8); LIT (Catheter, Angioplasty, Peripheral, Transluminal, 6); DQY (Catheter, Percutaneous, 5).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup